Page 103 - GPD-4-1

Gene & Protein in Disease Oral-ERT in PD knockout mice with tobrhGAA

human enzyme. Mol Ther. 2002;6:601-608. of a sibship. Ann Neurol. 1987;22:629-633.
44. Neufeld EF. Lysosomal storage diseases. Annu Rev Biochem. doi: 10.1002/ana.410220512
1991;60:257-280.
55. Kobayashi H, Shimada Y, Ikegami M, et al. Prognostic factors
doi: 10.1146/annurev.bi.60.070191.001353 for the late onset Pompe disease with enzyme replacement
therapy: From our experience of 4 cases including an
45. van den Hout JM, Reuser AJ, de Klerk JB, Arts WF,
Smeitink JA, van der Ploeg AT. Enzyme therapy for Pompe autopsy case. Mol Genet Metab. 2010;100:14-19.
disease with recombinant human a-glucosidase from rabbit doi: 10.1016/j.ymgme.2010.01.015
milk. J Inherit Metab Dis. 2001;24:266-274.
56. Kenney-Jung D, Korlimarla A, Spiridigliozzi GA, et al.
doi: 10.1023/a:1010383421286 Severe CNS involvement in a subset of long-term treated
children with infantile-onset Pompe disease. Mol Genet
46. Reuser AJ, Kroos MA, Hermans MM, et al. Glycogenosis
type II (acid maltase deficiency). Muscle Nerve Suppl. Metab. 2023;141:108119.
1995;3S:61-69. doi: 10.1016/j.ymgme.2023.108119
doi: 10.1002/mus.880181414 57. McCall AL, Dhindsa JS, Bailey AM, Pucci LA,
Strickland LM, Eimallah MK. Glycogen accumulation in
47. van den Hout H, Reuser AJ, Vulto AG, Loonen MC,
Cromme-Dijkhuis A, van der Ploeg AT. Recombinant smooth muscle of a Pompe disease mouse model. J Smooth
human a-glucosidase from rabbit milk in Pompe patients. Muscle Res. 2021;57:8-18.
Lancet. 2000;356:397-398. doi: 10.1540/jsmr.57.8
doi: 10.1016/s0140-6736(00)02533-2 58. Hundsberger T, Rohrbach M, Kern L, Rösler KM.
Swiss national guideline for reimbursement of enzyme
48. Amalfitano A, Bengur AR, Morse RP, et al. Recombinant
human acid a-glucosidase enzyme therapy for infantile replacement therapy in late-onset Pompe disease. J Neurol.
glycogen storage disease type II: Results of a phase I/II 2013;260:2279-2285.
clinical trial. Genet Med. 2001;3:132-138. doi: 10.1007/s00415-013-6980-5
49. Corti M, Liberati C, Smith BK, et al. Safety of 59. Kusnadi AR, Evangelista RL, Hood EE, Howard JA,
intradiaphragmatic delivery of adeno-associated virus Nikolov ZL. Processing of transgenic corn seed and its
mediated alpha-glucosidase (rAAV1-CMV-hGAA) gene effect on the recovery of recombinant beta-glucuronidase.
therapy in children affected by Pompe disease. Hum Gene Biotechnol Bioeng. 1998;60:44-52.
Ther Clin Dev. 2017;28:208-218.
doi: 10.1002/(sici)1097-0290(19981005)60:1<44:aid-bit5>3.0.co;2-0
doi: 10.1089/humc.2017.146
60. Reggi S, Marchetti S, Patti T, et al. Recombinant human
50. Miyamoto Y, Etoh Y, Joh R, Noda K, Ohya I, Morimatsu M. acid β-glucosidase stored in tobacco seed is stable, active
Adult-onset acid maltase deficiency in siblings. Acta Pathol and taken up by human fibroblasts. Plant Mol Biol. 2005;57:
Jpn. 1985;35:1533-1542. 101-113.
doi: 10.1111/j.1440-1827.1985.tb01450.x doi: 10.1007/s11103-004-6832-x
51. Anneser JMH, Pongratz DE, Podskarbi T, Shin YS, 61. Stoeger E, Vaquero C, Torres E, et al. Cereal crops as viable
Schoser BGH. Mutations in the acid a-glucosidase gene (M. production and storage systems for pharmaceutical scFv
Pompe) in a patient with an unusual phenotype. Neurology. antibodies. Plant Mol Biol. 2000;42:583-590.
2005;64:368-370.
doi: 10.1023/a:1006301519427
doi: 10.1212/01.WNL.0000149528.95362.20
62. Kermode AR. Plants as factories for production of
52. Refai D, Lev R, Cross DT, Shimony JS, Leonard JR. Thrombotic biopharmaceutical and bioindustrial proteins: Lessons from
complications of a basilar artery aneurysm in a young adult cell biology. Can J Bot. 2006;84:679-694.
with Pompe disease. Surg Neurol. 2008;70:518-520.
63. Kermode AR. Seed expression systems for molecular
doi: 10.1016/j.surneu.2007.05.049 farming. In: Wang A, Ma S, editors. Molecular Farming in
Plants: Recent Advances and Future Prospects. New York:
53. Kretzschmar HA, Wagner H, Hubner G, Danek A, Witt TN,
Mehraein P. Aneurysms and vacuolar degeneration of Springer; 2012. p. 89-123.
cerebral arteries in late-onset acid maltase deficiency. 64. Lau OS, Sun SSM. Plant seeds as bioreactors for recombinant
J Neurol Sci. 1990;98:169-183. protein production. Biotechnol Adv. 2009;27:1015-1022.
doi: 10.1016/0022-510x(90)90258-o doi: 10.1016/j.biotechadv.2009.05.005
54. Makos MM, McComb RD, Hart MN, Bennett DR. Alpha- 65. Fischer R, Schillberg S, Hellwig S, Twyman RM, Drossard J.
glucosidase deficiency and basilar artery aneurysm: Report GMP issues for recombinant plant-derived pharmaceutical

Volume 4 Issue 1 (2025) 17 doi: 10.36922/gpd.1760